• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1804350-23
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Low Blood Pressure/ Hypotension (1914); Thrombosis/Thrombus (4440)
Event Date 03/12/2022
Event Type  Injury  
Event Description
It was reported that on (b)(6) 2022, an emergency percutaneous coronary intervention (pci) procedure was performed on a patient with acute myocardial infarction who was taken from a different hospital.Complete occlusion on right coronary artery (rca), left circumflex (lcx), and acute coronary syndrome (acs) due to the heavy stenosis on left anterior descending (lad) artery were noted.Thrombectomy was performed on the lad.After intravascular ultrasound (ivus) and plain old balloon angioplasty (poba), pre-dilatation was performed on the proximal lad.The 3.5x23 mm xience skypoint stent delivery system (sds) and 3.0x33mm xience skypoint sds were deployed at the proximal lad and the mid lad.Calcification in the distal left circumflex (lcx) with 100% stenosis, lesion length 35mm, lesion radius 2.5mm and tortuosity and heavy calcification in the proximal lcx with 100% stenosis, lesion length 10mm, lesion radius 2.75mm were noted.A non-abbott guide wire and guiding catheter were inserted into lcx.After pre-dilatation by a non-abbott balloon catheter at lcx, a non-abbott stent was deployed at the proximal lcx and distal lcx, without post-dilatation.The stent expansion was confirmed by imaging.The patient was taken into critical care unit (ccu).On (b)(6) 2022, sudden changes occurred in the patient¿s condition and went into cardiac arrest.Occlusion occurred from ostia of lad and lcx due to thrombosis and was confirmed by imaging.Under intra-aortic balloon pump (iabp), the lesions were dilated with a balloon catheter, but the patient died due to a fall in blood pressure.According to the physician who performed the procedure, the cause of thrombosis was unknown.Medications were administered.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record and complaint history of the reported lot could not be conducted because the lot number was not provided.The reported patient effects of thrombosis and hypotension are listed in the xience skypoint, everolimus eluting coronary stent system (eecss), electronic instructions for use as known patient effects of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined; however, the reported treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.The additional skypoint device is being filed under a separate medwatch report number.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key14215060
MDR Text Key290149826
Report Number2024168-2022-04538
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648233418
UDI-Public08717648233418
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 04/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/26/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number1804350-23
Device Catalogue Number1804350-23
Was Device Available for Evaluation? No
Date Manufacturer Received04/05/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
3.0X33MM XIENCE SKYPOINT SDS
Patient Outcome(s) Required Intervention; Hospitalization;
Patient SexMale
-
-